Anmelden Kostenlos registrieren

QSAM Biosciences Umsatz

Was ist das Umsatz von QSAM Biosciences?

Umsatz von QSAM Biosciences, Inc. ist $0.00

Was ist die Definition von Umsatz?



Umsatz sind die Einnahmen, die ein Unternehmen aus seiner normalen Geschäftstätigkeit erzielt, normalerweise aus dem Verkauf von Waren und Dienstleistungen an Kunden.

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Umsatz von Unternehmen in Health Care Sektor auf OTC im Vergleich zu QSAM Biosciences

Was macht QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Unternehmen mit umsatz ähnlich QSAM Biosciences